Atlas Trials

Dose Escalation Study of Gemcitabine and ON 01910.Na in Solid Tumors

Clinical trial NCT01125891 · COMPLETED

Trial details

NCT number
NCT01125891
Sponsor
Traws Pharma, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Malignant NeoplasmasSolid Tumors
Start date
2009-01-01
Primary completion
2011-09-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.